{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:23:32Z","timestamp":1794349412466,"version":"4.9.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018806","name":"Department of Science and Technology of Hubei Province","doi-asserted-by":"publisher","award":["D20250014"],"award-info":[{"award-number":["D20250014"]}],"id":[{"id":"10.13039\/501100018806","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004374","name":"Chongqing Medical University","doi-asserted-by":"publisher","award":["2025QDLYZX-03"],"award-info":[{"award-number":["2025QDLYZX-03"]}],"id":[{"id":"10.13039\/501100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Chongqing Natural Science Foundation","doi-asserted-by":"publisher","award":["CSTB2024NSCQ-MSX0098"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX0098"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.isci.2026.117580","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:11:36Z","timestamp":1789758696000},"page":"117580","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanistic insights into VSIR-mediated AXL regulation and gastric cancer proliferation"],"prefix":"10.1016","volume":"29","author":[{"given":"Jinshan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoquan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjiang","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jilv","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bitao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.117580_bib1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Hyuna","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.isci.2026.117580_bib2","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1056\/NEJMoa001999","article-title":"Helicobacter pylori infection and the development of gastric cancer","volume":"345","author":"Uemura","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.117580_bib3","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.3390\/jcm9113699","article-title":"Helicobacter pylori-Mediated Immunity and Signaling Transduction in Gastric Cancer","volume":"9","author":"Ito","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.isci.2026.117580_bib4","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/cas.12205","article-title":"Tying the knot between cytokine and toll-like receptor signaling in gastrointestinal tract cancers","volume":"104","author":"Tye","year":"2013","journal-title":"Cancer Sci."},{"key":"10.1016\/j.isci.2026.117580_bib5","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.4049\/jimmunol.1002971","article-title":"IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3","volume":"186","author":"Greenhill","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2026.117580_bib6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ccr.2009.01.001","article-title":"IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer","volume":"15","author":"Grivennikov","year":"2009","journal-title":"Cancer cell"},{"key":"10.1016\/j.isci.2026.117580_bib7","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.3390\/cancers15123248","article-title":"Targeted Therapies and Developing Precision Medicine in Gastric Cancer","volume":"15","author":"Pihlak","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.isci.2026.117580_bib8","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2026.117580_bib9","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1038\/s12276-024-01336-6","article-title":"VISTA-mediated immune evasion in cancer","volume":"56","author":"Zhang","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.isci.2026.117580_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay0524","article-title":"VISTA is a checkpoint regulator for na\u00efve T cell quiescence and peripheral tolerance","volume":"367","author":"ElTanbouly","year":"2020","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.isci.2026.117580_bib11","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s00262-018-2227-8","article-title":"Expression of the inhibitory B7 family molecule VISTA in human colorectal carcinoma tumors","volume":"67","author":"Xie","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.isci.2026.117580_bib12","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.celrep.2019.12.036","article-title":"FOXD3 Regulates VISTA Expression in Melanoma","volume":"30","author":"Rosenbaum","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2026.117580_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1086102","article-title":"VISTA expression and patient selection for immune-based anticancer therapy","volume":"14","author":"Martin","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.117580_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1578","article-title":"Blockade of V-domain immunoglobulin suppressor of T-cell activation reprograms tumour-associated macrophages and improves efficacy of PD-1 inhibitor in gastric cancer","volume":"14","author":"Cao","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.isci.2026.117580_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40364-022-00394-0","article-title":"IGSF11 and VISTA: a pair of promising immune checkpoints in tumor immunotherapy","volume":"10","author":"Tang","year":"2022","journal-title":"Biomark. Res."},{"key":"10.1016\/j.isci.2026.117580_bib16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13046-023-02726-w","article-title":"AXL in cancer: a modulator of drug resistance and therapeutic target","volume":"42","author":"Tang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.117580_bib17","first-page":"2113","article-title":"A novel putative tyrosine kinase receptor with oncogenic potential","volume":"6","author":"Janssen","year":"1991","journal-title":"Oncogene"},{"key":"10.1016\/j.isci.2026.117580_bib18","first-page":"1900","article-title":"AXL is a marker for epithelial-mesenchymal transition in esophageal squamous cell carcinoma","volume":"15","author":"Zhang","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.isci.2026.117580_bib19","doi-asserted-by":"crossref","first-page":"9546","DOI":"10.18632\/oncotarget.2542","article-title":"AXL kinase as a novel target for cancer therapy","volume":"5","author":"Wu","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.isci.2026.117580_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107291","article-title":"Phase 1 trial of bemcentinib (BGB324), a first-in-class, selective AXL inhibitor, with docetaxel in patients with previously treated advanced non-small cell lung cancer","volume":"182","author":"Bhalla","year":"2023","journal-title":"Lung Cancer"},{"key":"10.1016\/j.isci.2026.117580_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41392-024-02121-7","article-title":"AXL signaling in cancer: from molecular insights to targeted therapies","volume":"10","author":"Yadav","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.isci.2026.117580_bib22","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3390\/cancers14030466","article-title":"AXL Receptor Tyrosine Kinase as a Promising Therapeutic Target Directing Multiple Aspects of Cancer Progression and Metastasis","volume":"14","author":"Goyette","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.isci.2026.117580_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1121130","article-title":"Gas6\/AXL pathway: immunological landscape and therapeutic potential","volume":"13","author":"Zhai","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.isci.2026.117580_bib24","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3390\/medicina61091619","article-title":"The Receptor Tyrosine Kinase Axl in (Advanced) Gastric Cancer-From Pathophysiology to Therapeutic Impact","volume":"61","author":"Schreiner","year":"2025","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.isci.2026.117580_bib25","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s10120-020-01066-4","article-title":"Inhibiting the GAS6\/AXL axis suppresses tumor progression by blocking the interaction between cancer-associated fibroblasts and cancer cells in gastric carcinoma","volume":"23","author":"Bae","year":"2020","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.isci.2026.117580_bib26","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.3390\/jcm13226694","article-title":"Association Between Phosphorylated AXL Expression and Survival in Patients with Gastric Cancer","volume":"13","author":"Ho","year":"2024","journal-title":"Journal of Clinical Medicine"},{"key":"10.1016\/j.isci.2026.117580_bib27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/mco2.11","article-title":"A dual MET\/AXL small-molecule inhibitor exerts efficacy against gastric carcinoma through killing cancer cells as well as modulating tumor microenvironment","volume":"1","author":"Zhu","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.isci.2026.117580_bib28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41467-018-08074-0","article-title":"AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells","volume":"10","author":"Taniguchi","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.117580_bib29","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.3390\/cancers12071850","article-title":"Gas6\/Axl Signaling Pathway in the Tumor Immune Microenvironment","volume":"12","author":"Tanaka","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.isci.2026.117580_bib30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.it.2020.12.008","article-title":"VISTA: A Mediator of Quiescence and a Promising Target in Cancer Immunotherapy","volume":"42","author":"Yuan","year":"2021","journal-title":"Trends Immunol."},{"key":"10.1016\/j.isci.2026.117580_bib31","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1038\/s41591-023-02465-7","article-title":"Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial","volume":"29","author":"Shah","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.117580_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/npjbcancer.2016.33","article-title":"AXL-associated tumor inflammation as a poor prognostic signature in chemotherapy-treated triple-negative breast cancer patients","volume":"2","author":"Bottai","year":"2016","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.isci.2026.117580_bib33","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1158\/1535-7163.MCT-19-0873","article-title":"Preclinical Activity of HER2-Selective Tyrosine Kinase Inhibitor Tucatinib as a Single Agent or in Combination with Trastuzumab or Docetaxel in Solid Tumor Models","volume":"19","author":"Kulukian","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.isci.2026.117580_bib34","doi-asserted-by":"crossref","first-page":"15374","DOI":"10.1021\/acs.jmedchem.2c01346","article-title":"Discovery of 3-Aminopyrazole Derivatives as New Potent and Orally Bioavailable AXL Inhibitors","volume":"65","author":"Chan","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.isci.2026.117580_bib35","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.immuni.2018.12.022","article-title":"The Lupus Susceptibility Locus Sgp3 Encodes the Suppressor of Endogenous Retrovirus Expression SNERV","volume":"50","author":"Treger","year":"2019","journal-title":"Immunity"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226029597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226029597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:39:04Z","timestamp":1794346744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226029597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2589004226029597"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.117580","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanistic insights into VSIR-mediated AXL regulation and gastric cancer proliferation","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.117580","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117580"}}